# CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors

> **NCT06646952** · — · RECRUITING · sponsor: **Hua Zhu** · enrollment: 30 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** 18F-FDG

## Key facts

- **NCT ID:** NCT06646952
- **Lead sponsor:** Hua Zhu
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06646952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06646952, "CD147 Targeting Nanobody Probe for PET Imaging in Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06646952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*